Latest European Federation of Pharmaceutical Industries and Associations Stories
NEW YORK, April 5, 2013 /PRNewswire/ -- As part of an ongoing industry-wide commitment to ensuring transparency in clinical studies, a group of pharmaceutical and biotechnology companies*, including AbbVie, AstraZeneca Pharmaceuticals LP, BiogenIdec, Bristol-Myers Squibb, EMD Serono, GlaxoSmithKline, Janssen, the Pharmaceutical Companies of Johnson & Johnson, Eli Lilly and Company, Merck & Co., Inc., Novartis, Novo Nordisk A/S, Roche, and Takeda Pharmaceuticals International,...
BUDAPEST, Hungary, BRUSSELS & LEIDEN, The Netherlands, February 28, 2013 /PRNewswire/ -- ChemAxon [http://www.chemaxon.com/#_blank ], a leader in providing chemistry software solutions and consulting services for life science research, and the European Lead Factory, a novel platform for innovative drug discovery, announces that ChemAxon will provide the core tools and leads the development of the informatics platform to support the panEuropean initiative. ChemAxon...
WELWYN GARDEN CITY, England and BOSTON, November 29, 2012 /PRNewswire/ -- Consortium supported with over EUR20 million funding from EU Innovative Medicines Initiative and big pharma Heptares Therapeutics, the leading GPCR drug discovery company, is joining a group of leading European academic and industry researchers known as the 'K4DD' ('Kinetics for Drug Discovery') Consortium to investigate binding kinetics or 'kinotypic'...
GENEVA, October 31, 2012 /PRNewswire/ -- - Commissioned by IFPMA, the study identifies tailored, consistent long-term government policies as key factors to foster biopharmaceutical innovation An independent study on biopharmaceutical innovation in middle-income countries was released today at the 26th IFPMA Assembly in Geneva. The report analyzed key national political and economic factors that foster biopharmaceutical innovation. The...
GENEVA, October 10, 2012 /PRNewswire/ -- - Publication contains recommendations for governments and other stakeholders to address MNDs - Research in this disease area is complex, time-consuming, and needs to be incentivized - Launch coincides with World Mental Health Day to raise awareness on the burden of mental and neurological disorders on society Today the International Federation of Pharmaceutical...
-- Four major pharmaceutical associations issue joint policy statement to crack down on counterfeits from illicit Internet pharmacies and other sources -- Statement comes as the U.S. launches Center for Safe Internet Pharmacies (CSIP) initiative WASHINGTON, July 23, 2012 /PRNewswire-USNewswire/ -- The global pharmaceutical industry unveiled recommendations today to tackle the growing public health threat of counterfeit or fake medicines. The industry's call for increased...
LONDON, June 20, 2011 /PRNewswire/ -- Pharma IQ has just published the results of an Industry-wide Pharmaceutical Distribution Survey, conducted recently among 3,000 pharmaceutical distribution specialist with over 83 % of those surveyed directly responsible for distribution at their respective companies. The results showed that that almost 75% of respondents are satisfied with the current level of service they received from external partners and solution providers they...
Global Health Progress highlights benefits of investment, including improving access to medicines and economic growth Washington, DC (PRWEB) October 22, 2010 A recent Global Health Progress fact sheet highlights how Mexico's investment in its biopharmaceutical sector has spurred economic growth, fostered global competitiveness, reduced the health and economic burden of disease on local citizens, and improved access to medicines. With the tenth largest economy in the world, Mexico is...
FRANKFURT, Germany and LAUSANNE, Switzerland and PARIS, June 14, 2010 /PRNewswire-FirstCall/ -- IMIDIA ("Innovative Medicines Initiative for Diabetes"), a public private consortium funded by the Innovative Medicines Initiative (IMI), announced today the launch of a project focusing on pancreatic islet cell function and survival. Academia, biotech and pharma industry have joined forces to develop biomarkers and tools to pave the way for improved disease management and ultimately provide...
NEW YORK, Nov. 3 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue. Impact of Counterfeits on Parallel Trade & Pharmaceutical Distribution: Issues, initiatives and insights for supply chain integrity...
